Cargando…
Dual time point [(18)F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues
PURPOSE: For differentiating tumor from inflammation and normal tissues, fluorodeoxyglucose ([(18)F]FDG) dual time point PET could be helpful. Albeit [(18)F]FLT is more specific for tumors than [(18)F]FDG; we explored the role of dual time point [(18)F]FLT-PET for discriminating benign from malignan...
Autores principales: | Lovinfosse, Pierre, Rousseau, Caroline, Pierga, Jean-Yves, Bouchet, Francis, Cochet, Alexandre, Alberini, Jean-Louis, Girault, Sylvie, Vera, Pierre, Olivier, Pierre, Uwer, Lionel, Cachin, Florent, Scarwell, Benoit, Lemonnier, Jérome, Fourme, Emmanuelle, Mesleard, Christel, Martin, Anne-Laure, Lacœuille, Franck, Couturier, Olivier-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908533/ https://www.ncbi.nlm.nih.gov/pubmed/31832803 http://dx.doi.org/10.1186/s13550-019-0579-5 |
Ejemplares similares
-
Calibration Test of PET Scanners in a Multi-Centre Clinical Trial on Breast Cancer Therapy Monitoring Using 18F-FLT
por: Bouchet, Francis, et al.
Publicado: (2013) -
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
por: Boughdad, Sarah, et al.
Publicado: (2020) -
Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model
por: Vanpouille-Box, Claire, et al.
Publicado: (2011) -
For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time
por: Sher, Avigaëlle, et al.
Publicado: (2016) -
Assessment of Inflammation and Calcification in Pseudoxanthoma Elasticum Arteries and Skin with 18F-FluroDeoxyGlucose and 18F-Sodium Fluoride Positron Emission Tomography/Computed Tomography Imaging: The GOCAPXE Trial
por: Omarjee, Loukman, et al.
Publicado: (2020)